Shares of Biogen soared almost 30% on Tuesday after the drugmaker introduced it was searching for regulatory approval for an Alzheimer's drug, aduc [...]
Biotech shares surged after Biogen introduced plans to revive its Alzheimer's drug aducanumab.The iShares NASDAQ Biotechnology ETF gained greater t [...]